BioMimetic Investor Says $380M Buyout Deal Doesn't Cut It
A BioMimetic Therapeutics Inc. investor launched a putative class action Wednesday protesting the orthopedic therapy company's planned $380 million buyout by Wright Medical Technology Inc., claiming the deal greatly undervalues a...To view the full article, register now.
Already a subscriber? Click here to view full article